Alternative complement pathway deregulation is correlated with dengue severity.
BACKGROUND
The complement system, a key component that links the innate and adaptive immune responses, has three pathways: the classical, lectin, and alternative pathways. In the present study, we have analyzed the levels of various complement components in blood samples from dengue fever (DF) and dengue hemorrhagic fever (DHF) patients and found that the level of complement activation is associated with disease severity.


RESULTS
Patients with DHF had lower levels of complement factor 3 (C3; p = 0.002) and increased levels of C3a, C4a and C5a (p<0.0001) when compared to those with the less severe form, DF. There were no significant differences between DF and DHF patients in the levels of C1q, immunocomplexes (CIC-CIq) and CRP. However, small but statistically significant differences were detected in the levels of MBL. In contrast, the levels of two regulatory proteins of the alternative pathway varied widely between DF and DHF patients: DHF patients had higher levels of factor D (p = 0.01), which cleaves factor B to yield the active (C3bBb) C3 convertase, and lower levels of factor H (p = 0.03), which inactivates the (C3bBb) C3 convertase, than did DF patients. When we considered the levels of factors D and H together as an indicator of (C3bBb) C3 convertase regulation, we found that the plasma levels of these regulatory proteins in DHF patients favored the formation of the (C3bBb) C3 convertase, whereas its formation was inhibited in DF patients (p<0.0001).


CONCLUSIONS
The data suggest that an imbalance in the levels of regulatory factors D and H is associated with an abnormal regulation of complement activity in DHF patients.
Nascimento
Eduardo J M
EJ
Division of Infectious Diseases, Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Silva
Ana M
AM
Cordeiro
Marli T
MT
Brito
Carlos A
CA
Gil
Laura H V G
LH
Braga-Neto
Ulisses
U
Marques
Ernesto T A
ET
D000293:Adolescent; D000328:Adult; D003167:Complement Activation; D003165:Complement System Proteins / Q000378:metabolism*; D003715:Dengue / Q000378:metabolism / Q000503:physiopathology*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D055815:Young Adult
D003165:Complement System Proteins
Viral Immunol. 2006 Summer;19(2):127-32
16817755
Ophthalmology. 2007 Sep;114(9):1743-7
17561258
Arch Med Res. 2005 Sep-Oct;36(5):425-35
16099317
PLoS Negl Trop Dis. 2008 Apr 09;2(4):e215
18398488
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15259-64
16217017
Am J Trop Med Hyg. 2007 Dec;77(6):1128-34
18165535
Curr Drug Targets. 2008 Feb;9(2):165-72
18288968
Expert Rev Mol Med. 2008 May 12;10:e12
18471342
Cell Host Microbe. 2007 Dec 13;2(6):417-26
18078693
PLoS One. 2009;4(4):e4945
19340301
J Infect Dis. 2008 May 15;197(10):1459-67
18444802
Immunobiology. 2005;209(9):689-97
15804047
J Clin Microbiol. 1992 Mar;30(3):545-51
1372617
Clin Infect Dis. 2006 Oct 15;43(8):1023-30
16983615
J Gen Virol. 1978 Sep;40(3):531-44
690610
Annu Rev Med. 2008;59:293-309
17705684
Mol Immunol. 2007 Sep;44(16):3862-5
17768104
J Med Virol. 2001 Feb;63(2):143-9
11170051
J Infect Dis. 2006 Apr 15;193(8):1078-88
16544248
Immunology. 2007 May;121(1):40-50
17244159
Allerg Immunol (Leipz). 1974-1975;20-21(4):385-92
4283486
Trans Assoc Am Physicians. 1973;86:102-10
4132983
Hum Immunol. 2008 Feb;69(2):122-8
18361938
J Cell Mol Med. 2008 Aug;12(4):1074-84
18419792
Blood. 2008 Dec 1;112(12):4542-5
18658028
Clin Exp Immunol. 2004 Nov;138(2):299-303
15498040
Am J Trop Med Hyg. 2008 Mar;78(3):370-4
18337328
Mol Vis. 2006 Dec 05;12:1536-42
17167412
Am J Trop Med Hyg. 1977 Sep;26(5 Pt 1):975-84
907057
J Exp Med. 1975 Jul 1;142(1):139-50
1097571
J Virol. 2008 Jan;82(2):927-37
18003724
Am J Trop Med Hyg. 1979 Sep;28(5):881-4
384817
Hum Mol Genet. 2006 Nov 1;15(21):3206-18
17000705
Blood. 2008 Jun 1;111(11):5307-15
18268093
N Engl J Med. 2001 Apr 5;344(14):1058-66
11287977
J Virol. 2008 Jul;82(13):6631-43
18448542
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19111-6
17132743
Ann N Y Acad Sci. 2007 Aug;1109:93-105
17785294
J Allergy Clin Immunol. 2005 May;115(5):911-9; quiz 920
15867843
J Clin Virol. 2007 Jun;39(2):76-81
17507286
Clin Infect Dis. 2006 Sep 15;43(6):800-1
16912966
Cardiovasc Hematol Disord Drug Targets. 2009 Mar;9(1):36-50
19275576
J Immunol. 1998 Dec 1;161(11):6338-46
9834124
Semin Thromb Hemost. 2006 Mar;32(2):128-45
16575688
Baillieres Best Pract Res Clin Haematol. 2000 Jun;13(2):261-76
10942625
Baillieres Clin Haematol. 1995 Mar;8(1):249-70
7663049
Pediatr Nephrol. 2000 Sep;14(10-11):1045-53
10975323
Mol Immunol. 2008 Mar;45(5):1199-207
17961651